Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Robert Eckel Added: 3 years ago
The more that is learned about the causes, treatment, and prevention of heart disease and stroke, the more the importance of a shared focus is appreciated. The American Heart Association (AHA) is working toward a 25% reduction in heart disease, stroke, and risk by 2010, and needs the commitment of the entire cardiology community to achieve that goal. The fight against cardiovascular disease is… View more

Prevention & Chronic Conditions
Author(s): Paul A Friedman , Stephen C Hammill Added: 3 years ago
Atrial fibrillation (AF) is a rhythm disturbance of the atria that results in irregular, chaotic, ventricular waveforms, varying from bradyarrhythmia to tachyarrhythmia. Essentially, all forms of AF therapy can be divided into two categories - restoration and maintenance of normal sinus rhythm, or control of the ventricular rate while permitting on-going fibrillation of the atria. Although… View more

Electrophysiology & Arrhythmia
View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 5 months ago
What are the top late-breaking trials from #TCT2023? TCT 2023 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference. Dive into this practical and engaging discussion and learn more about the… View more

Intervention
Portrait image of Stavros Stavrakis
Research Area(s) / Expertise:

Atrial Fibrillation

 Job title: Associate Professor of Medicine; Laureate Chair in Molecular Medicine; Vice Chief, Cardiovascular Section
Dr Stavrakis is a clinical cardiac electrophysiologist and Associate Professor of Medicine at the University of Oklahoma Health Sciences Center. He is also the Director of Cardiovascular Research at the University of Oklahoma. Dr Stavrakis’ research has focused on autonomic modulation for the treatment of arrhythmias and other cardiovascular diseases, in both animal models and humans. The… View more
TRISCEND Study: 6Mo Outcomes Show TR Reduction in Majority of Patients
Author(s): Susheel Kodali Added: 2 years ago
Dr Susheel Kodali (Columbia University Medical Center, New York, NY, US) discusses the six-month outcomes of the TRISCEND study.Originally presented at TCT 2021, this is a randomized multicenter controlled trial aiming to evaluate the safety and effectiveness of the EVOQUE tricuspid valve replacement system. At 6 months, the results suggest positive outcomes, with a reduction in tricuspid… View more

Intervention
Author(s): Oussama M Wazni , Allan L Klein Added: 3 years ago
Atrial fibrillation (AF) is the most commonly sustained arrhythmia with a prevalence of 0.4% in the general population1-4 affecting 2.3 million people in the US.5 The prevalence increases with age being <1% in persons younger than 60 years of age to >8% in those older than 80 years.1,5-8 The incidence ranges from 0.2% per year for men 30 to 39 years of age to 2.3% per year in men 80 to 89… View more

Imaging & Diagnostics
Foreword

Article

Author(s): Michael H Picard Added: 3 years ago
I am writing this note at an interesting time. I have just watched the inauguration of our newest US President and there is an air of refreshed enthusiasm across the country. At the same time, we are facing a continued downturn in our economy and the predictions for the near term are pessimistic. Thus, there is a paradoxical state of optimism mixed with fear. Healthcare reform has moved to the… View more

Digital Health
Author(s): Joanne D Schuijf Added: 3 years ago
Relationship Between Noninvasive Coronary Angiography With Multi-slice Computed Tomography and Myocardial Perfusion Imaging Schuijf JD, et al. J Am Coll Cardiol, 2006;48(12):2508–14. Epub 2006 Nov 28. The aim of this study was to perform a head-to-head comparison between multi-slice computed tomography (MSCT), which detects atherosclerosis, and myocardial perfusion imaging (MPI), which detects… View more

Imaging & Diagnostics
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 2 years ago
Learn about the key take-home messages from ACC.22 with View from the Thoraxcenter hosts, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this succinct review video, they summarise the top late-breaking science trials and share their take on how the new data can be translated into practice. Trials covered in detail include: 00:29: PACMAN AMI:… View more

Anticoagulation

Vascular Disease and Surgery
TCT 23: Late-Breaking Clinical Trials Revealed
Added: 6 months ago Source:  Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in… View more